Cardior Pharmaceuticals: Cardior Welcomes Dr. Orly Vardeny as Permanent Guest to the Board
Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced that Orly Vardeny, PharmD, MS, joins